Spikevax bivalent Original / Omicron 0.1 mg/mL dispersion for injection
Spikevax bivalent Original / Omicron is indicated as a booster dose for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Spikevax (previously COVID‑19 Vaccine Moderna)
The Brunei Darussalam Medicines Control Authority (BDMCA) has granted Special approval for Spikevax during public health emergency or pandemic situation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years of age and older.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Tools
Temperature Excursion Tool
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Contact Moderna